Equities Analysts Offer Predictions for DNTH Q2 Earnings
Dianthus Therapeutics, Inc. (NASDAQ:DNTH – Free Report) – Investment analysts at Lifesci Capital issued their Q2 2025 earnings per share estimates for shares of Dianthus Therapeutics in a report issued on Wednesday, June 18th. Lifesci Capital analyst R. Katkhuda forecasts that the company will post earnings of ($0.86) per share for the quarter. The consensus […]
Dianthus Therapeutics, Inc. (NASDAQ:DNTH – Free Report) – Investment analysts at Lifesci Capital issued their Q2 2025 earnings per share estimates for shares of Dianthus Therapeutics in a report issued on Wednesday, June 18th. Lifesci Capital analyst R. Katkhuda forecasts that the company will post earnings of ($0.86) per share for the quarter. The consensus […]
